$8.75
+0.92%
N/A+$0.08
Healthcare
Biotechnology
NASDAQ
Active Trading
Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein ...
PRTA
Generating AI CEO profile...
Key Risk
No major risk extracted yet.
Key Tailwind
No major tailwind extracted yet.